<?xml version="1.0"?>

<document>
	<title>Defective cellular immunity to gram-negative bacteria in cystic
   fibrosis patients.</title>

	<author>Sorensen-R-U.</author>
	<author>Stern-R-C.</author>
	<author>Chase-P.</author>
	<author>Polmar-S-H.</author>

	<source>Infect-Immun. 1979 Feb. 23(2). P 398-402.</source>

	<abstract>In vitro lymphocyte responses to Pseudomonas aeruginosa have been
   found to be impaired in cystic fibrosis patients with advanced
   clinical disease. The responses to Klebsiella pneumoniae, Serratia
   marcescens, and Proteus mirabilis were studied in a similar group of
   cystic fibrosis patients and normal individuals. Cystic fibrosis
   patients found to be unresponsive to pseudomonas were also
   unresponsive to klebsiella, serratia, and proteus. Responsiveness to
   Staphylococcus aureus was not impaired in cystic fibrosis patients.
   We postulate that in vitro lymphocyte responses to several gram-
   negative bacteria require the function of a lymphocyte subpopulation
   which may be impaired in some cystic fibrosis patients.</abstract>

	<majorsubject>ANTIGENS-BACTERIAL: im</majorsubject>
	<majorsubject>CYSTIC-FIBROSIS: im</majorsubject>
	<majorsubject>ENTEROBACTERIACEAE: im</majorsubject>
	<majorsubject>LYMPHOCYTE-TRANSFORMATION</majorsubject>
	<majorsubject>PSEUDOMONAS-AERUGINOSA: im</majorsubject>

	<minorsubject>HUMAN</minorsubject>
	<minorsubject>KLEBSIELLA-PNEUMONIAE: im</minorsubject>
	<minorsubject>PROTEUS-MIRABILIS: im</minorsubject>
	<minorsubject>SERRATIA-MARCESCENS: im</minorsubject>
	<minorsubject>SUPPORT-U-S-GOVT-P-H-S</minorsubject>

	<reference>001   CHANDRA RK            PEDIATRICS                      59   423 977</reference>
	<reference>002   DOERSHUK CF           J PEDIATR                       65   677 964</reference>
	<reference>003   FERGUSON AC           J PEDIATR                       85   717 974</reference>
	<reference>004   GREEN GM              AM REV RESPIR DIS              102   691 970</reference>
	<reference>005   GREEN GM              J EXP MED                      119   167 964</reference>
	<reference>006   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   559 974</reference>
	<reference>007   KALTREIDER HB         AM REV RESPIR DIS              113   347 976</reference>
	<reference>008   LIEBERMAN J           AM REV RESPIR DIS              116  1047 977</reference>
	<reference>009   MOORE VL              RES J RETICULOENDOTHEL SOC      21   131 977</reference>
	<reference>010   NEUMANN CG            AM J CLIN NUTR                  28    89 975</reference>
	<reference>011   PRESSMAN D            IN: SAUNTER M                         11 971</reference>
	<reference>012   SELLMEYER E           ARCH DIS CHILD                  47   429 972</reference>
	<reference>013   SHWACHMAN H           AM J DIS CHILD                  96     6 958</reference>
	<reference>014   SORENSEN RU           INFECT IMMUN                    18   735 977</reference>
	<reference>015   SORENSEN RU           J PEDIATR                       93   201 978</reference>
	<reference>016   THORSBY E             HISTOCOMPATIBILITY TESTING           655 970</reference>
	<reference>017   WALLWORK JC           CLIN EXP IMMUNOL                18   303 974</reference>
	<reference>018   WARR GA               AM REV RESPIR DIS              108   371 973</reference>
	<reference>019   WEIGLE WO             IMMUNOLOGY                       7   239 964</reference>
	<reference>020   WEIGLE WO             J EXP MED                      121   289 965</reference>
	<reference>021   WEIGLE WO             J IMMUNOL                       94   117 965</reference>

	<citation>1   RUUSKANEN O           J CLIN LAB IMMUNOL               4   111 980</citation>
	<citation>2   RUUSKANEN O           J IMMUNOL                      125   411 980</citation>
	<citation>3   MATTHEWS WJ           N ENGL J MED                   302   245 980</citation>
	<citation>4   SORENSEN RU           PEDIATR RES                     15    14 981</citation>
	<citation>5   JOHNSON DL            RES COMMUN CHEM PATH PHARM      32   377 981</citation>
	<citation>6   RUBIN HR              CELL IMMUNOL                    57   307 981</citation>
	<citation>7   SORENSEN RU           AM REV RESPIR DIS              123    37 981</citation>
	<citation>8   VANGEFFEL R           ANN IMMUNOL (PARIS)           D133   293 982</citation>
	<citation>9   WILSON GB             MED HYPOTHESES                   8   527 982</citation>
	<citation>10   SEALE TW              ANN CLIN LAB SCI                12   415 982</citation>
	<citation>11   LILLIE MA             J CLIN MICROBIOL                16   111 982</citation>
	<citation>12   WOLFE JHN             ARCH SURG                      117  1266 982</citation>
	<citation>13   MCIRVINE AJ           ANN SURG                       196   297 982</citation>
	<citation>14   GUIDOTTI TL           AM J MED SCI                   283   157 982</citation>
	<citation>15   RUBIN HR              INFECT IMMUN                    39   630 983</citation>
	<citation>16   PORWOLL JM            INFECT IMMUN                    40   670 983</citation>
	<citation>17   SORENSEN RU           INFECT IMMUN                    41   321 983</citation>
	<citation>18   MCIRVINE AJ           SURG CLIN NORTH AM              63   245 983</citation>
	<citation>19   SORENSEN RU           EUR J RESPIR DIS                64   524 983</citation>
	<citation>20   MILLER KM             CLIN EXP IMMUNOL                56   415 984</citation>
	<citation>21   AUERBACH HS           LANCET                           2   686 985</citation>
	<citation>22   SPEERT DP             SURV SYNTH PATHOL RES            4    14 985</citation>
	<citation>23   ZAPATASIRVENT RI      SURGERY                         97   721 985</citation>
	<citation>24   ZAPATASIRVENT RL      SURGERY                         99    53 986</citation>
	<citation>25   HANSBROUGH JF         AM J SURG                      151   249 986</citation>
	<citation>26   KEANE RM              IR J MED SCI                   155   143 986</citation>

</document>
